Francesco Angotzi

University of Padua

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Immunology Immunology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Collaborators (6)

Federica Frezzato

ITALY

View details

Francesca Romana Mauro

ITALY

View details

Alberto Fresa

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Francesco Piazza

Assistant Professor of Hematology

Università degli Studi della Campania Luigi Vanvitelli Scuola di Medicina e Chirurgia

ITALY

View details

Andrea Visentin

Assistant professor

University of Padua

ITALY

View details

Livio Trentin

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Francesco Angotzi

Research Interests

Explore related searches

Contact this professor

Articles (10)

Venetoclax based regimens in octogenarian CLL patients: efficacy, safety and comparison to BTKi in a multicenter cohort

Serum soluble interleukin‐2 receptor levels in hairy cell leukaemia as a marker of tumour burden with prognostic value and as a tool for disease monitoring

Management strategies for patients with chronic lymphocytic leukaemia harbouring complex karyotype

Exploring the prognostic role of complex karyotype in chronic lymphocytic leukaemia patients treated with venetoclax‐based regimens

Efficacy and safety of venetoclax plus hypomethylating agents in relapsed/refractory acute myeloid leukemia: a multicenter real-life experience

Chronic Lymphocytic Leukemia (CLL) with Borderline Immunoglobulin Heavy Chain Mutational Status, a Rare Subgroup of CLL with Variable Disease Course

How receptor tyrosine kinase‐like orphan receptor 1 meets its partners in chronic lymphocytic leukemia

Focal adhesion kinase activation by calcium‐dependent calpain is involved in chronic lymphocytic leukaemia cell aggressiveness

Continuous venetoclax in treatment‐naive <scp><i>TP</i>53</scp> disrupted patients with chronic lymphocytic leukemia: A chronic lymphocytic leukemia campus study

Tixagevimab/Cilgavimab as pre-exposure prophylaxis against SARS-CoV-2 in patients with hematological malignancies

Collaborators (6)

Federica Frezzato

Francesca Romana Mauro

Alberto Fresa

Francesco Piazza

Andrea Visentin

Livio Trentin

Make your next move.